Filters

Recombinant Human Proprotein Convertase Subtilisin, Kexin Type 9, PCSK9 (D374Y, C-6His)

Recombinant Human Proprotein Convertase Subtilisin, Kexin Type 9, PCSK9 (D374Y, C-6His) size: 50 µg 369

Supplier NOVO
Price 369
Size 50 µg
Reacts withHuman
Source proteins, Recombinants or rec
DescriptionRecombinant Human Proprotein Convertase 9 is produced by our Mammalian expression system and the target gene encoding Gln31-Gln692 is expressed with a 6His tag at the C-terminus
Molecular Weight1 kD, 71
UniProt numberQ8NBP7
State of the productLiquid
Shipping conditionsDry Ice/ice packs
Formulation 150 mM sodium chloride, pH 7, 2 um filtered solution of 50 mM HEPES, 4, Supplied as a 0
Storage recommendations -20°, Please minimize freeze-thaw cycles, stable for 6 months after receipt, C, Store at <
Reconstitution Dissolve the lyophilized protein in ddH2O, Do not mix by vortex or pipetting, It is not recommended to reconstitute to a concentration less than 100 &mu, Please aliquot the reconstituted solution to minimize freeze-thaw cycles, Always centrifuge tubes before opening, g/ml
Purity and determined by Polyacrylamide gel electrophoresis, Greater than 95%
Sequence of the amino acidQEDEDGDYEELVLALRSEEDGLAEAPEHGTTATFHRCAKDPWRLPGTYVVVLKEETHLSQSERTARRLQAQAARRGYLTKILHVFHGLLPGFLVKMSGDLLELALKLPHVDYIEEDSSVFAQSIPWNLERITPPRYRADEYQPPDGGSLVEVYLLDTSIQSDHREIEGRVMVTDFENVPEEDGTRFHRQASKCDSHGTHLAGVVSGRDAGVAKGASMRSLRVLNCQGKGTVSGTLIGLEFIRKSQLVQPVGPLVVLLPLAGGYSRVLNAACQRLARAGVVLVTAAGNFRDDACLYSPASAPEVITVGATNAQDQPVTLGTLGTNFGRCVDLFAPGEDIIGASSYCSTCFVSQSGTSQAAAHVAGIAAMMLSAEPELTLAELRQRLIHFSAKDVINEAWFPEDQRVLTPNLVAALPPSTHGAGWQLFCRTVWSAHSGPTRMATAIARCAPDEELLSCSSFSRSGKRRGERMEAQGGKLVCRAHNAFGGEGVYAIARCCLLPQANCSVHTAPPAEASMGTRVHCHQQGHVLTGCSSHWEVEDLGTHKPPVLRPRGQPNQCVGHREASIHASCCHAPGLECKVKEHGIPAPQEQVTVACEEGWTLTGCSALPGTSHVLGAYAVDNTCVVRSRDVSTTGSTSEEAVTAVAICCRSRHLAQASQELQHHHHHH
Levels of endotoxin11 IEU/ug, LAL test shows less than than 0
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Grouprecombinants
Gene target C-6His), Kexin 9, PCSK9 (D374Y, Proprotein Convertase Subtilisin
Short name C-6His), Kexin 9, PCSK9 (D374Y, Recombinant Proprotein Convertase Subtilisin
Technique E, coli recombinant proteins are , novo advises they will be reconstituted in a buffer soluion or culture medium for cell culture, supplied as white sterile powder lyopillized, Recombinant, genetic recombinations , in Escherichia coli
Species Humans, Human
Alternative name C-6His), Kexin classification 9, proprotein convertase subtilisin/kexin classification 9 (D374Y, sapiens Proprotein Convertase Subtilisin, recombinant H
Alternative techniquerec
Alternative to gene target Extracellular, PCSK9 and IDBG-99082 and ENSG00000169174 and 255738, Pcsk9 and IDBG-170186 and ENSMUSG00000044254 and 100102, this GO :0001822 and kidney development and biological process this GO :0001889 and liver development and biological process this GO :0001920 and negative regulation of receptor recycling and biological process this GO :0002092 and positive regulation of receptor internalization and biological process this GO :0004252 and serine-type endopeptidase activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005764 and lysosome and cellular component this GO :0005769 and early endosome and cellular component this GO :0005770 and late endosome and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0005791 and rough endoplasmic reticulum and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006508 and proteolysis and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0006644 and phospholipid metabolic process and biological process this GO :0006915 and apoptotic process and biological process this GO :0007041 and lysosomal transport and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0009267 and cellular response to starvation and biological process this GO :0009986 and cell surface and cellular component this GO :0010469 and regulation of receptor activity and biological process this GO :0010989 and negative regulation of low-density lipoprotein particle clearance and biological process this GO :0016485 and protein processing and biological process this GO :0016540 and protein autoprocessing and biological process this GO :0019871 and sodium channel inhibitor activity and molecular function this GO :0022008 and neurogenesis and biological process this GO :0030134 and ER to this GO lgi transport vesicle and cellular component this GO :0030169 and low-density lipoprotein particle binding and molecular function this GO :0030182 and neuron differentiation and biological process this GO :0031232 and extrinsic component of external side of plasma membrane and cellular component this GO :0032799 and low-density lipoprotein receptor particle metabolic process and biological process this GO :0032802 and low-density lipoprotein particle receptor catabolic process and biological process this GO :0032803 and regulation of low-density lipoprotein particle receptor catabolic process and biological process this GO :0032869 and cellular response to insulin stimulus and biological process this GO :0034185 and apolipoprotein binding and molecular function this GO :0034189 and very-low-density lipoprotein particle binding and molecular function this GO :0034190 and apolipoprotein receptor binding and molecular function this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042632 and cholesterol homeostasis and biological process this GO :0043523 and regulation of neuron apoptotic process and biological process this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0043621 and protein self-association and molecular function this GO :0044822 and poly(A) RNA binding and molecular function this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0050750 and low-density lipoprotein particle receptor binding and molecular function this GO :0070326 and very-low-density lipoprotein particle receptor binding and molecular function, this GO :0004252: serine-type endopeptidase activity, this GO :0004252: serine-type endopeptidase activity and also this GO :0005515: protein binding and also this GO :0019871: sodium channel inhibitor activity and also this GO :0030169: low-density lipoprotein particle binding and also this GO :0034185: apolipoprotein binding and also this GO :0034189: very-low-density lipoprotein particle binding and also this GO :0034190: apolipoprotein receptor binding and also this GO :0043621: protein self-association and also this GO :0044822: poly(A) RNA binding and also this GO :0050750: low-density lipoprotein particle receptor binding and also this GO :0070326: very-low-density lipoprotein particle receptor binding, this GO :0005515: protein binding, this GO :0019871: sodium channel inhibitor activity, this GO :0030169: low-density lipoprotein particle binding, this GO :0034185: apolipoprotein binding, this GO :0034189: very-low-density lipoprotein particle binding, this GO :0034190: apolipoprotein receptor binding, this GO :0043621: protein self-association, this GO :0044822: poly(A) RNA binding, this GO :0050750: low-density lipoprotein particle receptor binding, this GO :0070326: very-low-density lipoprotein particle receptor binding, very-low-density lipoprotein particle receptor binding, proprotein convertase subtilisin/kexin type 9
Identity 20001
Gene PCSK9
Long gene name proprotein convertase subtilisin/kexin type 9
Synonyms gene HCHOLA3
Synonyms gene name autosomal dominant 3 , hypercholesterolemia
Synonyms NARC-1 FH3
Locus 1p32, 3
Discovery year 2003-05-13
GenBank acession AX207686
Entrez gene record 255738
Pubmed identfication 12552133 12730697
RefSeq identity NM_174936
Classification Proprotein convertase subtilisin/kexin family
Havana BLAST/BLAT OTTHUMG00000008136
Locus Specific Databases British Heart Foundation LRG_275

Subscribe to our Newsletter